MAIA Biotechnology, Inc. Annual Operating Income (Loss) in USD from 2021 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
MAIA Biotechnology, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2021 to 2023.
  • MAIA Biotechnology, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$3.82M, a 18.2% increase year-over-year.
  • MAIA Biotechnology, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$19.1M, a 5.28% decline year-over-year.
  • MAIA Biotechnology, Inc. annual Operating Income (Loss) for 2023 was -$20.2M, a 24.8% decline from 2022.
  • MAIA Biotechnology, Inc. annual Operating Income (Loss) for 2022 was -$16.2M, a 108% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$20.2M -$4.01M -24.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 -$16.2M -$8.39M -108% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 -$7.79M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.